Sulconazole nitrate cream 1 percent for treating tinea cruris and corporis. 1989

L Tanenbaum, and D Taplin, and C Lavelle, and W A Akers, and M J Rosenberg, and G Carmargo
Syntex Research, Palo Alto, California.

Sulconazole nitrate 1 percent cream, a new imidazole derivative, was tested in 117 Colombian Army soldiers with tinea cruris/corporis under hot, humid conditions. The results of two clinical trials demonstrate that sulconazole applied once daily was as effective as clotrimazole applied twice daily. After three weeks of therapy 100 percent of the patients treated either once or twice daily with sulconazole showed negative findings on potassium hydroxide preparations and cultures from lesions. Although sulconazole was well tolerated and caused no adverse reactions, four of twenty-seven clotrimazole-treated patients showed reactions consisting of erosive primary irritation. Sulconazole nitrate 1 percent cream appears to be highly effective in the treatment of tinea cruris/corporis when applied once or twice daily and may be very useful in hot and humid conditions where contact irritation reactions occur more often.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D003022 Clotrimazole An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal CELL MEMBRANES. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane. Bay b 5097,Canesten,FB b 5097,Kanesten,Klotrimazole,Lotrimin,Mycelex
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004643 Emollients Oleagenous substances used topically to soothe, soften or protect skin or mucous membranes. They are used also as vehicles for other dermatologic agents. Emollient
D004821 Epidermophyton A fungal genus which grows in the epidermis and is the cause of TINEA. Epidermophytons
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L Tanenbaum, and D Taplin, and C Lavelle, and W A Akers, and M J Rosenberg, and G Carmargo
July 1982, Cutis,
L Tanenbaum, and D Taplin, and C Lavelle, and W A Akers, and M J Rosenberg, and G Carmargo
March 1995, Cutis,
L Tanenbaum, and D Taplin, and C Lavelle, and W A Akers, and M J Rosenberg, and G Carmargo
April 2014, Indian dermatology online journal,
L Tanenbaum, and D Taplin, and C Lavelle, and W A Akers, and M J Rosenberg, and G Carmargo
January 1988, Journal of the American Academy of Dermatology,
L Tanenbaum, and D Taplin, and C Lavelle, and W A Akers, and M J Rosenberg, and G Carmargo
January 1990, International journal of dermatology,
L Tanenbaum, and D Taplin, and C Lavelle, and W A Akers, and M J Rosenberg, and G Carmargo
November 2013, Indian journal of dermatology,
L Tanenbaum, and D Taplin, and C Lavelle, and W A Akers, and M J Rosenberg, and G Carmargo
March 2000, European journal of dermatology : EJD,
L Tanenbaum, and D Taplin, and C Lavelle, and W A Akers, and M J Rosenberg, and G Carmargo
July 2003, Dermatologic clinics,
L Tanenbaum, and D Taplin, and C Lavelle, and W A Akers, and M J Rosenberg, and G Carmargo
August 2014, The Cochrane database of systematic reviews,
L Tanenbaum, and D Taplin, and C Lavelle, and W A Akers, and M J Rosenberg, and G Carmargo
August 1984, Cutis,
Copied contents to your clipboard!